• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类认知神经科学在痴呆症药物研发中的作用。

The role of human cognitive neuroscience in drug discovery for the dementias.

机构信息

Bracket, Goring-on-Thames, UK; Department of Psychology, Northumbria University, Newcastle, UK; Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.

Formerly Bracket, Goring-on-Thames, UK.

出版信息

Curr Opin Pharmacol. 2014 Feb;14:62-73. doi: 10.1016/j.coph.2013.12.001. Epub 2013 Dec 22.

DOI:10.1016/j.coph.2013.12.001
PMID:24565014
Abstract

Cognitive dysfunction characterizes all the various forms of dementia. Evidence is accumulating that all of the progressive neurodegenerative dementias, such as Alzheimer's disease (AD), are preceded by years, if not decades, of pathological cognitive decline. The limited effectiveness of the four current medications registered for AD together with the failure of dozens of programmes over the last decade has influenced the decision to evaluate treatment at earlier stages of the disease; even before any cognitive symptoms have appeared. However, it has to be acknowledged that treating mild cognitive impairment (MCI) as a prodrome for AD has also had very limited success. Nonetheless a more important problem in MCI research, and dementia in general, has to be laid at the door of the limited effectiveness of the cognitive tests employed. This problem will become even more severe for the latest research direction of treating preclinical AD because such individuals will have levels of cognitive abilities which are in the normal range; and thus many of the scales currently used in dementia research will not be sufficiently demanding to identify change over time. This paper reviews and discusses the methodology and instruments available for research and clinical practice in this major area; with a focus on the challenges involved in test selection and evaluation.

摘要

认知功能障碍是所有类型痴呆的特征。有证据表明,所有进行性神经退行性痴呆,如阿尔茨海默病(AD),在出现病理认知下降的数年甚至数十年前就已经存在。目前用于 AD 的四种药物的疗效有限,以及过去十年数十个项目的失败,影响了在疾病早期阶段评估治疗的决定;甚至在出现任何认知症状之前。然而,必须承认,将轻度认知障碍(MCI)视为 AD 的前驱期,也取得了非常有限的成功。尽管如此,在 MCI 研究中,甚至在一般痴呆症研究中,一个更重要的问题必须归咎于所使用的认知测试的有限效果。对于治疗临床前 AD 的最新研究方向来说,这个问题将变得更加严重,因为这些个体的认知能力水平处于正常范围内;因此,目前用于痴呆症研究的许多量表在识别随时间变化方面的要求不够高。本文回顾和讨论了这一主要领域的研究和临床实践中可用的方法和工具;重点讨论了测试选择和评估所涉及的挑战。

相似文献

1
The role of human cognitive neuroscience in drug discovery for the dementias.人类认知神经科学在痴呆症药物研发中的作用。
Curr Opin Pharmacol. 2014 Feb;14:62-73. doi: 10.1016/j.coph.2013.12.001. Epub 2013 Dec 22.
2
Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.从轻度认知障碍到中度痴呆的步态表型:GOOD计划的结果
Eur J Neurol. 2016 Mar;23(3):527-41. doi: 10.1111/ene.12882. Epub 2015 Dec 14.
3
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].[美国国立衰老研究所和阿尔茨海默病协会关于阿尔茨海默病诊断指南的2011年新建议:临床前阶段、轻度认知障碍和痴呆症]
Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.
4
5
[From mild cognitive impairment to dementia: what is the role of public health?].[从轻度认知障碍到痴呆症:公共卫生的作用是什么?]
Recenti Prog Med. 2017 May;108(5):211-215. doi: 10.1701/2695.27557.
6
Mild cognitive impairment and preclinical Alzheimer's disease.轻度认知障碍和临床前阿尔茨海默病
Geriatrics. 2005 Jun;Suppl:9-14.
7
Mechanisms of vascular disease in dementia: what does industry want to know?
Clin Sci (Lond). 2017 May 1;131(9):799-802. doi: 10.1042/CS20160724.
8
Diet and Alzheimer's disease risk factors or prevention: the current evidence.饮食与阿尔茨海默病的风险因素或预防:现有证据。
Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56.
9
Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.阿尔茨海默病所致痴呆和轻度认知障碍的药物治疗。
Curr Opin Psychiatry. 2011 Nov;24(6):556-61. doi: 10.1097/YCO.0b013e32834b7b96.
10
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.用于治疗痴呆症状的乙酰胆碱酯酶抑制剂——安全性评估
Expert Opin Drug Saf. 2017 Sep;16(9):1009-1019. doi: 10.1080/14740338.2017.1351540. Epub 2017 Jul 12.

引用本文的文献

1
Development of a disulfidptosis-related prognostic model for endometrial cancer with potential therapeutic target.用于子宫内膜癌的二硫键连接性坏死相关预后模型的开发及潜在治疗靶点
Discov Oncol. 2024 Oct 4;15(1):521. doi: 10.1007/s12672-024-01384-4.
2
Effect of Chlorogenic Acids on Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial.没食子酸对认知功能的影响:一项随机、双盲、安慰剂对照试验。
Nutrients. 2018 Sep 20;10(10):1337. doi: 10.3390/nu10101337.